A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With ARDS

NCT05497401 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

ARDS

Interventions

BIOLOGICAL: MesenCure
OTHER: Placebo

Sponsor

BonusBio Group Ltd